Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06941038
What this trial is testing

Intraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Bladder Cancer RecurrenceIntravesical InstillationUpper Urinary Tract Carcinoma
Ankara Etlik City Hospital 270
Testing effectiveness (Phase 2)Looking for participantsNCT05528458
What this trial is testing

Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma
Samsung Medical Center 59
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Early research (Phase 1)Study completedNCT00533585
What this trial is testing

BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 23
Not applicableLooking for participantsNCT06345508
What this trial is testing

Early Detection of Liver Cancer by QUS

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 328
Not applicableStudy completedNCT06233708
What this trial is testing

Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant

Who this might be right for
Hepatocellular Carcinoma RecurrentHepatocellular Carcinoma
Asan Medical Center 2,092
Not applicableUnknownNCT03657017
What this trial is testing

PET/MR in Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaPET/MR
Zhejiang Cancer Hospital 150
Large-scale testing (Phase 3)Active Not RecruitingNCT03178552
What this trial is testing

Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,000
Not applicableEnded earlyNCT04688749
What this trial is testing

Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage

Who this might be right for
Melanoma (Skin)Basal Cell CarcinomaSquamous Cell Carcinoma+5 more
Aristotle University Of Thessaloniki 50
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Large-scale testing (Phase 3)Study completedNCT00158678
What this trial is testing

IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC

Who this might be right for
Oral CancerOropharynx CancerHypopharynx Cancer
Groupe Oncologie Radiotherapie Tete et Cou 310
Large-scale testing (Phase 3)UnknownNCT04053985
What this trial is testing

The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 206
Testing effectiveness (Phase 2)Study completedNCT00212043
What this trial is testing

Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma

Who this might be right for
Non Small Cell Lung Cancer
National University Hospital, Singapore 74
Early research (Phase 1)Study completedNCT00022308
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center
Early research (Phase 1)Study completedNCT00450138
What this trial is testing

Open Label, Phase I ZD6474 Head and Neck Cancer Study

Who this might be right for
Head and Neck Cancer
Sanofi 48
Early research (Phase 1)Study completedNCT02722538
What this trial is testing

Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer

Who this might be right for
Urinary Bladder Cancer
Taris Biomedical LLC 23
Testing effectiveness (Phase 2)Study completedNCT02535338
What this trial is testing

Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT02339558
What this trial is testing

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Nonkeratinizing CarcinomaRecurrent Nasopharynx CarcinomaStage III Nasopharyngeal Carcinoma AJCC v7+4 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07416058
What this trial is testing

PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC

Who this might be right for
Lung Adenocarcinoma
Guangdong Association of Clinical Trials 61
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07151326
What this trial is testing

Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
National Health Research Institutes, Taiwan 60
Next Page